rs771076928
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000104.4(CYP1B1):c.535delG(p.Ala179fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000512 in 1,563,088 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: 𝑓 0.000059 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000050 ( 0 hom. )
Consequence
CYP1B1
NM_000104.4 frameshift
NM_000104.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.0270
Genes affected
CYP1B1 (HGNC:2597): (cytochrome P450 family 1 subfamily B member 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The enzyme encoded by this gene localizes to the endoplasmic reticulum and metabolizes procarcinogens such as polycyclic aromatic hydrocarbons and 17beta-estradiol. Mutations in this gene have been associated with primary congenital glaucoma; therefore it is thought that the enzyme also metabolizes a signaling molecule involved in eye development, possibly a steroid. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most 50 bp of the penultimate exon, not predicted to undergo nonsense mediated mRNA decay. There are 123 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 2-38074853-GC-G is Pathogenic according to our data. Variant chr2-38074853-GC-G is described in ClinVar as [Pathogenic]. Clinvar id is 523943.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-38074853-GC-G is described in Lovd as [Pathogenic]. Variant chr2-38074853-GC-G is described in Lovd as [Likely_pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYP1B1 | NM_000104.4 | c.535delG | p.Ala179fs | frameshift_variant | 2/3 | ENST00000610745.5 | NP_000095.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYP1B1 | ENST00000610745.5 | c.535delG | p.Ala179fs | frameshift_variant | 2/3 | 1 | NM_000104.4 | ENSP00000478561.1 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152238Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
9
AN:
152238
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000512 AC: 8AN: 156224Hom.: 0 AF XY: 0.0000467 AC XY: 4AN XY: 85666
GnomAD3 exomes
AF:
AC:
8
AN:
156224
Hom.:
AF XY:
AC XY:
4
AN XY:
85666
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000503 AC: 71AN: 1410732Hom.: 0 Cov.: 31 AF XY: 0.0000531 AC XY: 37AN XY: 697332
GnomAD4 exome
AF:
AC:
71
AN:
1410732
Hom.:
Cov.:
31
AF XY:
AC XY:
37
AN XY:
697332
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152356Hom.: 0 Cov.: 33 AF XY: 0.0000671 AC XY: 5AN XY: 74508
GnomAD4 genome
AF:
AC:
9
AN:
152356
Hom.:
Cov.:
33
AF XY:
AC XY:
5
AN XY:
74508
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Glaucoma 3A Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein | Jan 31, 2023 | ACMG classification criteria: PVS1 very strong, PM2 supporting, PM3 strong - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 01, 2002 | - - |
Pathogenic, no assertion criteria provided | research | Institute of Medical Molecular Genetics, University of Zurich | Aug 01, 2019 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | 3billion | Jan 03, 2022 | Frameshift: predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant (PVS1_VS). It is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.000048, PM2_M). The variant has been reported at least twice as pathogenic/likely pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000523943, PMID:12372064).Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. - |
Anterior segment dysgenesis 6 Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 20, 2024 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 01, 2002 | - - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jun 02, 2023 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 23, 2018 | The c.535delG variant in the CYP1B1 gene has been reported previously in association with autosomal recessive primary congenital glaucoma, and has been reported as a founder mutation in the Moroccan population (Belmouden et al., 2002; Gronskov et al., 2016). This variant causes a frameshift starting with codon Alanine 179, changes this amino acid to an Arginine residue, and creates a premature Stop codon at position 18 of the new reading frame, denoted p.Ala179ArgfsX18. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The c.535delG variant is observed in 4/26120 (0.015%) alleles from individuals of Latino background and 7/182840 (0.004%) global alleles in large population cohorts, with no homozygotes identified (Lek et al., 2016). We interpret c.535delG as a pathogenic variant. - |
Glaucoma 3, primary infantile, B;C1856439:Glaucoma 3A;C4310623:Anterior segment dysgenesis 6 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Aug 30, 2021 | - - |
Primary congenital glaucoma Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Sep 10, 2024 | Variant summary: CYP1B1 c.535delG (p.Ala179ArgfsX18) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 5.1e-05 in 156224 control chromosomes (gnomAD). c.535delG has been reported in the literature in at least an individual affected with Primary Congenital Glaucoma (example: Reis_2016). These data indicate that the variant may be associated with disease. The following publication has been ascertained in the context of this evaluation (PMID: 27272408). ClinVar contains an entry for this variant (Variation ID: 523943). Based on the evidence outlined above, the variant was classified as pathogenic. - |
CYP1B1-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 07, 2023 | The CYP1B1 c.535delG variant is predicted to result in a frameshift and premature protein termination (p.Ala179Argfs*18). This variant was reported in the homozygous or compound heterozygous state to be causative for primary congenital glaucoma (described as 4339delG, Bouyacoub et al. 2014. PubMed ID: 24942078; Cardoso et al. 2015. PubMed ID: 25952714; García-Antón et al. 2017. PubMed ID: 28448622). This variant is reported in 0.019% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/2-38301996-GC-G). Frameshift variants in CYP1B1 are expected to be pathogenic. This variant is interpreted as pathogenic. - |
Congenital glaucoma Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 21, 2023 | This sequence change creates a premature translational stop signal (p.Ala179Argfs*18) in the CYP1B1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CYP1B1 are known to be pathogenic (PMID: 9097971, 9497261, 19234632). This variant is present in population databases (rs771076928, gnomAD 0.02%). This premature translational stop signal has been observed in individuals with open-angle glaucoma, and primary congenital glaucoma (PMID: 12372064, 19234632, 23922489, 27272408, 27777502, 27820421). It has also been observed to segregate with disease in related individuals. This variant is also known as c.4339delG, c.906delG, c.534_535delG (p.Ala179ArgfsX16). ClinVar contains an entry for this variant (Variation ID: 523943). For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at